Clinical Trial Update: Low-Dose Taxotere® (Docetaxel) With Concurrent Radiotherapy For Localized, Inoperable Carcinoma Of The Uterine Cervix [Phase 2]

View source ↗

Summary

Phase 2 trial of low-dose docetaxel (Taxotere) with concurrent radiotherapy for localized, inoperable cervical cancer has completed enrollment; results are not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer

Drugs mentioned

• Taxotere (docetaxel)

Snippet

Sponsor: University of Rochester | Conditions: Cervix Neoplasm | Phase 2 | Status: COMPLETED